Lataa...
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
BACKGROUND: Reversing multidrug resistance (MDR) has been an important goal for clinical and investigational oncologists. In the last few decades, significant effort has been made to search for inhibitors to reverse MDR by targeting ATP-binding cassette (ABC) transporters (Pgp, MRP) directly, but th...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4177239/ https://ncbi.nlm.nih.gov/pubmed/25236161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-681 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|